RBC
MDT icon

Roble Belko & Company’s Medtronic MDT Stock Holding History

Roble Belko & Company’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52K Hold
667
– – 0.01% 212
2026
Q1 		$58K Buy
667
+150
+29% +$14.4K 0.01% 198
2025
Q4 		$50K Sell
517
-14
-3% -$1.36K 0.01% 206
2025
Q3 		$51K Hold
531
– – 0.01% 168
2025
Q2 		$46K Sell
531
-18
-3% -$1.53K 0.01% 180
2025
Q1 		$49K Buy
549
+535
+3,821% +$47.9K 0.01% 169
2024
Q4 		$1K Hold
14
– – ﹤0.01% 342
2024
Q3 		$1K Buy
+14
New +$1.18K ﹤0.01% 318
2022
Q2 		– Sell
-190
Closed -$21K – 358
2022
Q1 		$21K Buy
190
+152
+400% +$16.1K ﹤0.01% 234
2021
Q4 		$4K Sell
38
-15
-28% -$1.74K ﹤0.01% 295
2021
Q3 		$7K Hold
53
– – ﹤0.01% 256
2021
Q2 		$7K Hold
53
– – ﹤0.01% 274
2021
Q1 		$6K Buy
53
+15
+39% +$1.76K ﹤0.01% 268
2020
Q4 		$4K Hold
38
– – ﹤0.01% 267
2020
Q3 		$4K Sell
38
-62
-62% -$6.23K ﹤0.01% 269
2020
Q2 		$9K Hold
100
– – ﹤0.01% 259
2020
Q1 		$9K Hold
100
– – ﹤0.01% 250
2019
Q4 		$11K Hold
100
– – ﹤0.01% 257
2019
Q3 		$11K Hold
100
– – ﹤0.01% 252
2019
Q2 		$10K Hold
100
– – ﹤0.01% 257
2019
Q1 		$9K Hold
100
– – ﹤0.01% 233
2018
Q4 		$9K Hold
100
– – ﹤0.01% 213
2018
Q3 		$10K Hold
100
– – ﹤0.01% 221
2018
Q2 		$9K Sell
100
-732
-88% -$61.1K ﹤0.01% 239
2018
Q1 		$67K Sell
832
-88
-10% -$7.26K 0.03% 107
2017
Q4 		$74K Buy
+920
New +$73.7K 0.03% 96
2016
Q2 		– Sell
-68
Closed -$5K – 289
2016
Q1 		$5K Sell
68
-232
-77% -$17.5K ﹤0.01% 195
2015
Q4 		$23K Buy
+300
New +$22.6K 0.01% 121

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Roble Belko & Company's MDT Position: Q2 2026 in Review

Roble Belko & Company held its Medtronic (MDT) position steady in Q2 2026 at 667 shares worth $52K. The position accounts for 0.01% of the portfolio, ranked #212.

Roble Belko & Company first reported a position in MDT in Q4 2015 and has held it in 28 quarters since. The position peaked at $74K in Q4 2017. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Roble Belko & Company held 667 shares of Medtronic worth $52K as of Q2 2026.
  • Roble Belko & Company left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.01% of Roble Belko & Company's portfolio in Q2 2026, its #212 holding.
  • Roble Belko & Company first reported a position in Medtronic in Q4 2015 and has held it in 28 quarters since.
  • Roble Belko & Company's Medtronic position peaked at $74K in Q4 2017.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.